Zacks Investment Research downgraded shares of RTI Surgical, Inc. (NASDAQ:RTIX) from a hold rating to a sell rating in a report released on Thursday morning.

According to Zacks, “RTI Surgical Inc. is a surgical implant company. Its implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures. RTI Surgical Inc., formerly known as RTI Biologics, Inc., is headquartered in Alachua, Fla. “

Separately, BidaskClub downgraded shares of RTI Surgical from a buy rating to a hold rating in a research report on Tuesday, August 8th.

Shares of RTI Surgical (NASDAQ:RTIX) opened at 4.75 on Thursday. The stock has a 50 day moving average price of $4.58 and a 200 day moving average price of $4.81. RTI Surgical has a 1-year low of $2.50 and a 1-year high of $6.00. The company’s market capitalization is $280.41 million.

RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.02 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.02. RTI Surgical had a negative net margin of 6.53% and a positive return on equity of 2.07%. The company had revenue of $72.10 million during the quarter, compared to the consensus estimate of $70.25 million. The firm’s revenue was up 6.7% on a year-over-year basis. Analysts forecast that RTI Surgical will post $0.06 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “RTI Surgical, Inc. (RTIX) Cut to “Sell” at Zacks Investment Research” was first posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/rti-surgical-inc-rtix-cut-to-sell-at-zacks-investment-research/1618647.html.

In other news, EVP John N. Varela acquired 12,000 shares of the firm’s stock in a transaction that occurred on Friday, August 11th. The shares were acquired at an average cost of $4.85 per share, with a total value of $58,200.00. Following the completion of the purchase, the executive vice president now directly owns 47,998 shares of the company’s stock, valued at approximately $232,790.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Nicholas J. Valeriani acquired 5,500 shares of the firm’s stock in a transaction that occurred on Monday, August 21st. The stock was purchased at an average cost of $4.70 per share, for a total transaction of $25,850.00. Following the completion of the purchase, the director now directly owns 47,754 shares of the company’s stock, valued at $224,443.80. The disclosure for this purchase can be found here. 4.90% of the stock is currently owned by insiders.

A number of large investors have recently made changes to their positions in RTIX. Rutabaga Capital Management LLC MA bought a new position in RTI Surgical in the second quarter valued at approximately $4,939,000. AJO LP bought a new position in RTI Surgical in the second quarter valued at approximately $2,597,000. Wedge Capital Management L L P NC bought a new position in RTI Surgical in the second quarter valued at approximately $1,471,000. Kennedy Capital Management Inc. increased its stake in RTI Surgical by 20.0% in the first quarter. Kennedy Capital Management Inc. now owns 1,422,371 shares of the medical equipment provider’s stock valued at $5,689,000 after acquiring an additional 236,923 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in RTI Surgical by 4.0% in the second quarter. Dimensional Fund Advisors LP now owns 4,056,932 shares of the medical equipment provider’s stock valued at $23,733,000 after acquiring an additional 156,901 shares during the last quarter. 69.99% of the stock is currently owned by institutional investors and hedge funds.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.